Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetics-based Efficacy Analysis: Ustekinumab Versus Secukinumab for the Treatment of Generalized Pustular Psoriasis

NCT06391996 is registered in ClinicalTrials.gov with Chao Ji as lead sponsor.

NCT NCT06391996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06391996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetics-based Efficacy Analysis: Ustekinumab Versus Secukinumab for the Treatment of Generalized Pustular Psoriasis
Lead sponsor
Chao Ji
Phase
Observational
Overall status
Completed
Start date
July 1, 2019
Completion date
December 30, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized pustular psoriasis